INTRODUCTION
In normal subjects, the rate of urea breakdown in the gastrointestinal tract is about one-fourth its excreted rate (1, 2) . The ammonia thus formed is largely reincorporated into urea in the liver, although some exchange of '5N-labeled ammonia with amino acid nitrogen occurs (3) . In uremia, the combined effects of reduced renal clearance and increased plasma concentration of urea might easily result in an increase in urea breakReceived for publication 29 October 1973 and in revised form 17 December 1973. down, both in absolute terms and as a fraction of urea produced. Available evidence indicates that this does indeed occur (2, (4) (5) (6) (7) (8) .
When dietary protein is restricted, this influx of portal ammonia could promote nitrogen conservation, as has been suggested (8) (9) (10) (11) . In diets containing essential amino acids but little or no nonessential nitrogen, ammonia nitrogen could be utilized for synthesis of nonessential amino acids. In diets containing nitrogen-free analogues of essential amino acids (a-ketoacids or a-hydroxyacids) portal ammonia could be used to convert these analogues to essential amino acids. In either case, the rate of appearance of urea (measured as the sum of urea excretion and the change in the urea pool) should be low under such circumstances, because much of the urea produced by the liver would be used synthetically.
Thus intestinal degradation of urea may be beneficial to the uremic subject maintained on a low protein diet. On the other hand, the quantity of ammonia released into the portal circulation could be far in excess of the daily requirements for synthesis of amino acids. For example, one uremic patient I studied apparently degraded 17 g urea N daily (8) , and two subjects studied by Jones, Smallwood, Craigie, and Rosenoer (2) were both found to degrade 15 g daily.
Continual breakdown of a major portion of synthesized urea is energetically wasteful. Furthermore, continued influx of such large amounts of ammonia into the liver might induce metabolic derangements.
The present studies were undertaken to determine the extent of urea degradation in severely uremic patients being maintained on low protein intakes, supplemented by essential amino acids or their keto-or hydroxyanalogues.
METHODS
On a total of 16 occasions, 13 Daily 24-h urea excretion and plasma urea were measured throughout the study, and urea pool was calculated as previously described (12) . The Urea kinetics in a "semi-steady" state. In normal subjects under ordinary circumstances, the urea pool changes little from day to day. Adjustment to altered nitrogen intake can be achieved within a few days. Thus a steady state of urea production and excretion is readily attained. In severe uremia, by contrast, the urea pool is rarely constant, because adjustment of excretion to an altered state of urea production may require weeks. The time constant of approach to a new steady state is roughly proportional to the urea clearance, which may be only a few percent of normal. Furthermore, because of the greatly enlarged urea pool, small fractional changes in this pool may constitute significant amounts of nitrogen. Hence any model of urea kinetics in uremia based on the steady-state assumption is inadequate. An alternative assumption is that the renal clearance (CR), extrarenal clearance (CM), and appearance rate (U) are constant. These are the parameters which determine the final steady-state value of the urea pool, but these quantities must remain constant for several weeks (in severe uremia) before the steady state is achieved. As shown below, methods for testing the validity of these assumptions in a given subject are available. Total clearance, C(= C3 + Cm) is thus obtained as kV. Confidence limits of CT are calculated as previously described (16) using a computer program. The rate of urinary excretion of ordinary urea, R, on any given day is defined by C3 = R/(P/0.95), and the rate of extrarenal disappearance, M, is defined by CM=M/(P/0.95). Ci and Cm are assumed constant, although R, M, and P may all be changing slightly fromn day to day. Thus M may be calculated as (kV -CB) X (P/0.95).
Urea appearance rate, U, is defined by U=. A-M,, (4) where A is urea production (12). As noted above, U is assumed to be constant during the period of observation. The average value of M during the period of observation may therefore be added to the measured value of U to obtain an estimate of A. No estimate is obtained by these methods of the contribution of portal ammonia to urea production.
The implicit assumption is also made here that the renal and extrarenal clearances of labeled and unlabeled urea are the same. In normal subjects, specific activity of urinary urea slightly exceeds the specific activity of plasma urea (1) . However, the explanation of this difference that has been generally accepted (17) , namely that urine urea is in equilibrium with a substantial pool of urea in the kidney, is probably inapplicable in severe uremia. Robson (4) The plasma disappearance curves for all of the experiments are shown in Fig. 1, and Extrarenal clearance of urea in normal subjects averages about 18 liters/day (1, 2). In both groups of uremic patients, far lower values were observed (average = 3.1 liters/day). But when this value is multiplied by mean plasma urea N concentration, 1.1 g/liter, the resulting rate of urea N degradation, 3.5 g/day, is close FIGURE 3 Relationship between urea production and urea degradation. Symbols as in Fig. 2 . The diagonal line -of identity is shown. The correlation is highly significant (r = 0.76, P <0.001), suggesting that most of the N derived from urea degradation is converted back to urea rather than being used for protein synthesis. to the reported normal value, 4'g/day (1, 2). Thus, in these patients, urea is being broken down at a normal rate, in absolute terms. There is in fact no significant correlation in these data between urea degradation and plasma urea concentration (r = 0.45, P > 0.05). Urea degradation as a fraction of urea production averaged 70%, far greater than normal, as has been noted previously (2, 5) . This fraction gives a somewhat misleading impression of the magnitude of urea degradation, since degradation is not in fact increased in these subjects when measured in absolute terms or in relation to plasma urea concentration.
The results were examined to determine whether low values of urea appearance, which is a desirable clinical goal, are correlated with high or low values of extrarenal clearance or urea degradation. As shown in Fig.  2 , there was no correlation between urea appearance and extrarenal clearance. Furthermore, repeated measurements (in three subjects) showed no consistent relationship between spontaneous changes in urea degradation and the rate of urea appearance. The correlation between urea appearance and urea degradation was also insignificant (r =-0.22, P > 0.1).
However, urea production was highly correlated with urea degradation (r = 0.76, P < 0.001) as shown in Fig. 3 . DISCUSSION Urea degradation in uremic patients has long been held to be increased (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . When data on which this inference is based are examined. carefully, it is by no means apparent that such is the case. In the first such study (5) As shown in Fig. 4 , these three observations are far removed from the data of the present study and those of Robson (4) .
Several possible explanations of these discrepancies deserve consideration. The patients in the present study all received essential amino acids or their analogues, whereas the patients in the previous studies received low protein diets alone. This cannot be the explanation of the difference, because Robson's (4, 5) subjects were also on protein restriction alone.
['N]Urea was used in the study I reported previously (8 cor- relation is found in the data in this study or in Robson's (4) data. Furthermore, there is no basis for concentration dependence of a diffusion-limited system in the absence of a carrier. The absence of urea in fecal fluid of uremic patients (9) gives no clue as to the extent of urea hydrolysis that has occurred.
Second, high blood urea may alter bowel flora in such a way that urea-splitting enzyme activity is reduced. According to Brown, Hill, and Richards (18) the opposite is the case: chronic uremic patients exhibit increased urease activity in feces. Furthermore, the same negative correlation should be observed. Third, some other component of the chronic uremic state may reduce urea-splitting in the gut. This seems more consistent with the present data, but is more a description of the results than a mechanism.
The role of urea degradation in N balance is not established by these observations because the extent to which portal ammonia is used for protein synthesis is not revealed. However, the strong correlation (r = 0.76) between urea degradation and production ( Fig. 3) suggests that a major portion of urea production is derived from portal ammonia. 'TN incorporation data (3) do not give a reliable quantitative estimate because of the uncertain contribution of exchange reactions (19 A simpler approach to this problem is a comparison of urea appearance rates before and after intestinal bacteriostasis. Clearly, a negative urea appearance rate must become positive when M is eliminated, as shown by Eq. 4. A positive appearance rate could also increase if a substantial contribution of portal ammonia were thereby eliminated. The present data, however, fail to support the commonly held view that intestinal degradation of urea facilitates N conservation.
